DexCom is trading 4.06% lower at $83.37 on October 6, 2026; the reason for the decline remains unclear.
- The company announced a new season of its Dexcom U college-athlete program, but the announcement does not explain the drop.
- The S&P 500, Nasdaq and Dow are each up more than 0.5%, so the provided market context does not establish a broad-market explanation.